Interactions of amyloid β peptide 1-40 and cerebrosterol

Neurochemical Research

Volumn 37, Issue 3, 2012, Pages 604-613

  Krištofiková, Zdena ^a   Kříž, Zdeněk ^b   Řípová, Daniela ^a   Koča, Jaroslav ^b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Alzheimer disease; Amyloid peptide; Oxysterol; Stereospecificity

Indexed keywords

24 HYDROXYCHOLESTEROL; AMYLOID BETA PROTEIN[1-40]; HEMICHOLINIUM 3; ISOPROTEIN; STEROL; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ANISOTROPY; ARTICLE; BINDING AFFINITY; BIOACCUMULATION; BRAIN SYNAPTOSOME; CHOLINE UPTAKE; CONTROLLED STUDY; ENANTIOMER; HYDROGEN BOND; HYDROPHOBICITY; IN VITRO STUDY; MALE; MOLECULAR DOCKING; MOLECULAR STABILITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; RAT; STEREOSPECIFICITY; STRUCTURE ACTIVITY RELATION;

AMYLOID BETA-PEPTIDES; ANIMALS; HIPPOCAMPUS; HYDROXYCHOLESTEROLS; MALE; PEPTIDE FRAGMENTS; PROTEIN BINDING; RATS; RATS, WISTAR;

RATTUS;

EID: 84862851803     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-011-0650-8     Document Type: Article

References (40)

1. Esteban JA (2004) Living with the enemy: a physiological role for the b-amyloid peptide. Trends Neurosci 27:1-3 (Pubitemid 38036969)
2. Koudinov AR, Berezov TT (2004) Alzheimer's amyloid beta (Ab) is an essential synaptic protein, not neurotoxic junk. Acta Neurobiol Exp 64:71-79 (Pubitemid 38453807)
3. Pearson HA, Peers C (2006) Physiological roles for amyloid b peptides. J Physiol 575:5-10
4. Gong Y, Chang L, Viola KL, Lacor PN, Lambert MP, Finch CE, Krafft GA, Klein WL (2003) Alzheimer's disease-affected brain: Presence of oligomeric Ab ligands (ADDLs) suggests a molecular basis for reversible memory loss. PNAS 100:10417-10422 (Pubitemid 37071893)
5. Yan SD, Fu J, Soto C, Chen X, Zhu H, Al-Mohanna F, Collison K, Zhu A, Stern E, Saido T, Tohyama M, Ogawa S, Roher A, Stern D (1997) An intracellular protein that binds amyloid-b peptide and mediates neurotoxicity in Alzheimer's disease. Nature 389:689-695 (Pubitemid 27458947)
6. Auld D, Kar S, Quirion R (1998) β-Amyloid peptides as direct cholinergic neuromodulator: a missing link? Trends Neurosci 21: 43-49 (Pubitemid 128766378)
7. Kar S, Issa AM, Seto D, Auld DS, Collier B, Quirion R (1998) Amyloid β-peptide inhibits high-affinity choline uptake and acetylcholine release in rat hippocampal slices. J Neurochem 70: 2179-2187 (Pubitemid 28207844)
8. Krištofiková Z, Tejkaloá H, Klaschka J (2001) Amyloid beta peptide 1-40 and the function of rat hippocampal hemicholinium3 sensitive choline carriers: effects of a proteolytic degradation in vitro. Neurochem Res 26:203-212 (Pubitemid 32692084)
9. Khan GM, Tong M, Jhun M, Arora K, Nichols RA (2010) β-Amyloid activates presynaptic alpha7 nicotinic acetylcholine receptors reconstituted into a model nerve cell system: involvement of lipid rafts. Eur J Neurosci 31:788-796
10. Ciccotosto GD, Tew DJ, Drew SC, Smith DG, Johanssen T, Lal V, Lau TL, Perez K, Curtain CC, Wade JD, Separovic F, Masters CL, Smith JP, Barnham KJ, Cappai R (2011) Stereo-specific interactions are necessary for Alzheimer disease amyloid-β toxicity. Neurobiol Aging 32:235-248
11. Esler WP, Stimson ER, Fishman JB, Ghilardi JR, Vinters HV, Mantyh PW, Maggio JE (1999) Stereochemical specificity of Alzheimer's disease β-peptide assembly. Biopolymers 49: 505-514 (Pubitemid 29157362)
12. Ban T, Hoshino M, Takahashi S, Hamada D, Hasegawa K, Naiki H, Goto Y (2004) Direct observation of Abeta amyloid fibril growth and inhibition. J Mol Biol 344:757-767 (Pubitemid 39469218)
13. Wadai H, Yamaguchi K, Takahashi S, Kanno T, Kawai T, Naiki H, Goto Y (2005) Stereospecific amyloid-like fibril formation by a peptide fragment of b2-microglobulin. Biochemistry 44: 157-164 (Pubitemid 40095717)
14. Gupta VB, Indi SS, Rao KSJ (2007) Studies on the role of amino acid stereospecificity in amyloid beta aggregation. J Mol Neurosci 34:35-43 (Pubitemid 351378087)
15. Tjernberg LO, Lilliehook C, Callaway DJE, Naslund J, Hahne S, Thyberg J, Terenius L, Nordstedt C (1997) Controlling amyloid β-peptide fibril formation with protease-stable ligands. J Biol Chem 272:12601-12605 (Pubitemid 27203354)
16. Verdier Y, Zarándi M, Penke B (2004) Amyloid β-peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease. J Pept Sci 10:229-248 (Pubitemid 38594184)
17. Kremer JJ, Sklansky DJ, Murphy RM (2001) Profile of changes in lipid bilayer structure caused by β-amyloid peptide. Biochemistry 40:8563-8571 (Pubitemid 32667263)
18. Boland K, Behrens M, Choi D, Manias K, Perlmutter DH (1996) The serpin-enzyme complex receptor recognizes soluble, nontoxic amyloid-b peptide but not aggregated, cytotoxic amyloid-b peptide. J Biol Chem 271:18032-18044 (Pubitemid 26250789)
19. Cribbs DH, Pike CJ, Weinstein SL, Velazques P, Cotman CW (1997) All D-enantiomers of β-amyloid exhibit similar biological properties to all-L-β-amyloids. J Biol Chem 272:7431-7436 (Pubitemid 27166455)
20. Cotman CW (1997) The β-amyloid peptide, peptide self-assembly, and the emergence of biological acitivities. A new principle in peptide function and the induction of neuropathology. Ann NY Acad Sci 814:1-16
21. Vargas J, Alarcón JM, Rojas E (2000) Displacement currents associated with the insertion of Alzheimer disease amyloid β-peptide into planar bilayer membranes. Biophys J 79:934-944 (Pubitemid 30626185)
22. Allen DD, Galdzicki Z, Brining SK, Fukuyama R, Rapoport SI, Smith QR (1997) Beta-amyloid induced increase in choline flux across PC12 cell membranes. Neuroci Lett 234:71-73 (Pubitemid 27435972)
23. Björkhem I (2007) Rediscovery of cerebrosterol. Lipids 42:5-14 (Pubitemid 46490739)
24. Yao ZX, Brown RC, Teper G, Greeson J, Papadopoulos V (2002) 22R-Hydroxycholesterol protects neuronal cells from β-amyloidinduced cytotoxicity by binding to β-amyloid peptide. J Neurochem 83:1110-1119 (Pubitemid 35397121)
25. Krištofiková Z, Kopecký V, Hofbauerová K, Hovorková P, Řípová D (2008) Complex of amyloid β peptides with 24-hydroxycholesterol and its effect on hemicholinium-3 sensitive carriers. Neurochem Res 33:412-421 (Pubitemid 351230441)
26. Bretillon L, Lütjohann D, Stähle L, Widhe T, Bindl L, Eggertsen G, Diczfalusy U, Björkhem I (2000) Plasma levels of 24Shydroxycholesterol reflect the balance between cerebral production and hepatic metabolism and are inversely related to body surface. J Lipid Res 41:840-845 (Pubitemid 30314140)
27. Kölsch H, Lütjohann D, Ludwig M, Schulte A, Ptok U, Jessem F, von Bergmann K, Rao ML, Maier W, Heun R (2002) Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease. Mol Psychiatry 7:899-902
28. Brown J, Theisler C, Silberman S, Magnuson D, Gottardi-Littell N, Lee JM, Yager D, Crowley J, Sambamurti K, Rahman MM, Reiss AB, Eckman ChB, Woloyin B (2004) Differential expression of cholesterol hydroxylases in Alzheimer's disease. J Biol Chem 279:34674-34681 (Pubitemid 39318097)
29. Kölsch H, Lütjohann D, Jessen F, Popp J, Hentschel F, Kelemen P, Schmitz S, Maier W, Heun R (2009) CYP46A1 variants influence Alzheimer's disease risk and brain cholesterol metabolism. Eur Psychiatry 24:183-190
30. Famer D, Meaney S, Mousavi M, Nordberg A, Björkhem I, Crisby M (2007) Regulation of a-and β-secretase activity by oxysterols: cerebrosterol stimulates processing of APP via the a-secretase pathway. Biochem Biophys Res Commun 359:46-50 (Pubitemid 46844819)
31. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantitites of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
32. Shen CL, Murphy RM (1995) Solvent effects on self-assembly of β-amyloid peptide. Biophys J 69:640-651
33. Krištofiková Z, Benešová O, Tejkalová H (1993) Comparison of the effects of aging in vivo and of oxygen free radicals in vitro on high-affinity choline uptake and hemicholinium-3 binding in the rat brain. Arch Gerontol Geriatr 17:179-188 (Pubitemid 24038796)
34. Tomaselli S, Esposito V, Vangone P, van Nuland NAJ, Bonvin AMJJ, Guerrini R, Tancredi T, Temussi PA, Picone D (2006) The a-to-b conformational transition of Alzheimer's Aβ-(1-42) pep-tide in aqueous media is reversible: a step by step conformational analysis suggests the location of b conformation seeding. ChemBioChem 7:257-267 (Pubitemid 43220939)
35. Grubmuller H, Groll V (1996) SOLVATE version 1.0. Institute for Medical Optics, University of Munich, Munich
36. Case DA, Darden TA, Cheatham TE III, Simmerling CL, Wang J, Duke RE, Luo R, Crowley M, Walker RC, Zhang W, Merz KM, Wang B, Hayik S, Roitberger A, Seabra G, Kolossváry I, Wong KF, Paesani F, Vanicek J, Wu X, Brozell SR, Steinbrecher T, Gohlke H, Yang L, Tan C, Mongan J, Hornak V, Cui G, Mathews DH, Seetin MG, Sagui C, Babin V, Kollman PA (2008) AMBER 10. University of California, San Francisco
37. Ryckaert JP, Ciccotti G, Berendsen HJC (1977) Numerical integration of the Cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J Comput Phys 23: 327-341
38. Shao J, Tanner SW, Thompson N, Cheatham TE III (2007) Clustering molecular dynamics trajectories:1. Characterizing the performance of different clustering algorithms. J Chem Theory Comput 3:2312-2334
39. Lang PT, Brozell SR, Mukherjee S, Pettersen EF, Meng EC, Thomas V, Rizzo RC, Case DA, James TL, Kuntz ID (2009) DOCK 6: combining techniques to model RNA-small molecule complexes. RNA 15:1219-1230
40. Onufriev A, Bashford D, Case DA (2004) Exploring protein native states and large-scale conformational changes with a modified generalized Born model. Proteins 55:383-394 (Pubitemid 38437495)